Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Player Avatar spindlelady (66.54) Submitted: 11/14/2012 12:24:38 PM : Outperform Start Price: $7.40 ARNA Score: +16.13

Has a diet drug approved and about to be marketed.

Featured Broker Partners